StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Net financial derivatives fair value in Net Debt by Quarter

Net financial derivatives fair value in Net Debt ($M) ($M)

QuarterlyAnnual

AstraZeneca Net financial derivatives fair value in Net Debt: $359M in Q2 2026, down 28.8% from a year earlier.

Latest, Q2 2026
359
Period ended Jun 30, 2026
Change on a year earlier
-28.8%
504 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Net derivatives | 359 | 507 | 504”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Net Debt Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet financial derivatives fair value in Net Debt ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026359-28.8%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026299+62.5%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025507+614.1%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025485+70.8%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025504+278.9%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025184+127.2%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202471-52.7%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024284+215.6%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024133+137.5%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202481-485.7%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023150-256.2%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202390-163.8%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202356-216.7%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023-21-135.6%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-96-257.4%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-141-256.7%Form 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Net financial derivatives fair value in Net Debt ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/nd-net-derivatives

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.